CD274 and cancer: Rencent studies suggest that anti-PD-(L)1 relies on the activation of memory (like) T cells or exhausted precursors T cells (52, 56), while activation of terminally exhausted T cells may promotes tumor progression by modulating cancer stem cells (95).